Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Beryllium Induces Premature Senescence in Human Fibroblasts

Shannon S. A. Coates, Bruce E. Lehnert, Sunil Sharma, Susan M. Kindell and Ronald K. Gary
Journal of Pharmacology and Experimental Therapeutics July 2007, 322 (1) 70-79; DOI: https://doi.org/10.1124/jpet.106.118018
Shannon S. A. Coates
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce E. Lehnert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunil Sharma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan M. Kindell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald K. Gary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

After cells have completed a sufficient number of cell divisions, they exit the cell cycle and enter replicative senescence. Here, we report that beryllium causes proliferation arrest with premature expression of the principal markers of senescence. After young presenescent human fibroblasts were treated with 3 μM BeSO4 for 24 h, p21 cyclin-dependent kinase inhibitor mRNA increased by >200%. Longer periods of exposure caused mRNA and protein levels to increase for both p21 and p16(Ink4a), a senescence regulator that prevents pRb-mediated cell cycle progression. BeSO4 also caused dose-dependent induction of senescence-associated β-galactosidase activity (SA-β-gal). Untreated cells had 48 relative fluorescence units (RFU)/μg/h of SA-β-gal, whereas 3 μM BeSO4 caused activity to increase to 84 RFU/μg/h. In chromatin immunoprecipitation experiments, BeSO4 caused p53 protein to associate with its DNA binding site in the promoter region of the p21 gene, indicating that p53 transcriptional activity is responsible for the large increase in p21 mRNA elicited by beryllium. Forced expression of human telomerase reverse transcriptase (hTERT) rendered HFL-1 cells incapable of normal replicative senescence. However, there was no difference in the responsiveness of normal HFL-1 fibroblasts (IC50 = 1.9 μM) and hTERT-immortalized cells (IC50 = 1.7 μM) to BeSO4 in a 9-day proliferation assay. The effects of beryllium resemble those of histone deacetylase-inhibiting drugs, which also cause large increases in p21. However, beryllium produced no changes in histone acetylation, suggesting that Be2+ acts as a novel and potent pharmacological inducer of premature senescence.

Footnotes

  • This study was supported by National Institutes of Health Grant P20 RR-016464 from the Idea Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources.

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

  • doi:10.1124/jpet.106.118018.

  • ABBREVIATIONS: CDK, cyclin-dependent kinase; SA-β-gal, senescence-associated β-galactosidase; HDAC, histone deacetylase; PD, population doubling; X-gal, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside; MUG, 4-methylumbelliferyl-β-d-galactopyranoside; PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis; HRP, horseradish peroxidase; TRAP, telomere repeat amplification protocol; PCR, polymerase chain reaction; ChIP, chromatin immunoprecipitation; gapdh, glyceraldehyde-3-phosphate dehydrogenase; Ct, threshold cycle; RFU, relative fluorescence unit(s); RNAP, RNA polymerase II; hTERT, human telomerase reverse transcriptase.

    • Received November 30, 2006.
    • Accepted March 28, 2007.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 381 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 381, Issue 2
1 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Beryllium Induces Premature Senescence in Human Fibroblasts
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Beryllium Induces Premature Senescence in Human Fibroblasts

Shannon S. A. Coates, Bruce E. Lehnert, Sunil Sharma, Susan M. Kindell and Ronald K. Gary
Journal of Pharmacology and Experimental Therapeutics July 1, 2007, 322 (1) 70-79; DOI: https://doi.org/10.1124/jpet.106.118018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Beryllium Induces Premature Senescence in Human Fibroblasts

Shannon S. A. Coates, Bruce E. Lehnert, Sunil Sharma, Susan M. Kindell and Ronald K. Gary
Journal of Pharmacology and Experimental Therapeutics July 1, 2007, 322 (1) 70-79; DOI: https://doi.org/10.1124/jpet.106.118018
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • ML355 Effects on Platelets
  • H2S Activates Heme-Inhibited mitoBKCa Channels
  • Insulin Regulates Gene Expression of Midnolin
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics